What is the treatment for exit site infections in Continuous Ambulatory Peritoneal Dialysis (CAPD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Exit Site Infections in CAPD

Start empiric antibiotics targeting Gram-positive organisms (particularly staphylococci) immediately after obtaining exit site cultures, treat for 7-14 days, and reserve catheter removal only for treatment failure, tunnel infection, or peritonitis development. 1

Initial Assessment and Culture Collection

Before initiating any antibiotic therapy, obtain cultures from the exit site drainage to guide definitive treatment and prevent antibiotic resistance. 1

  • Swab any visible exudate at the exit site for both culture and Gram staining 1
  • Collect blood cultures only if systemic infection signs are present (fever, chills, hemodynamic instability) 1
  • Consider ultrasound evaluation if clinical response is uncertain or to assess for tunnel involvement—a sonolucent zone >1 mm around the external cuff after antibiotic treatment predicts poor clinical outcome 2

Empiric Antibiotic Therapy

Empiric coverage must focus on Gram-positive organisms, especially staphylococci, as these are the most common pathogens. 1

  • Start empiric antibiotics immediately after culture collection 1
  • Oral ciprofloxacin (500 mg twice daily) can successfully treat the majority (83%) of Pseudomonas exit site infections when combined with local care 3
  • Modify antibiotics once culture and sensitivity results return to targeted therapy 1

Treatment Duration

Standard treatment is 7-14 days for uncomplicated exit site infections. 1 Continue therapy for 2 days after signs and symptoms resolve, though complicated infections may require longer courses. 4

Catheter Management Strategy

The catheter does NOT require removal for exit site infections alone in most cases. 1 Management depends on the causative organism and treatment response:

Indications for Catheter Removal:

  • Failure to respond to appropriate antibiotics after adequate treatment duration 1
  • Development of tunnel infection or peritonitis 1
  • Pseudomonas aeruginosa infections have uniformly poor outcomes regardless of sonographic findings, with 28% requiring catheter removal 5, 2
  • Mycobacterial infections require catheter removal in up to 40% of cases 5
  • Staphylococcus aureus infections require removal in approximately 35% of cases 5

Salvage Procedures Before Removal:

If tunnel infection develops with antibiotic-resistant S. aureus, consider deroofing and outer cuff shaving—this resolves infection in approximately 48% of cases without catheter removal. 6 If this fails, proceed to catheter exchange with a new subcutaneous tunnel to preserve the access site. 1

Organism-Specific Considerations

Pseudomonas aeruginosa: Despite oral ciprofloxacin success in 83% of cases, approximately 17% require catheter removal and 22% develop peritonitis months after apparent resolution. 3 Long-term gentamicin use may lead to 14% resistance rates. 5

Staphylococcus aureus: Associated with up to 50% of peritonitis cases when ESI is present. 5 Approximately 20% of all peritonitis episodes are preceded by exit site infections. 5

Critical Pitfalls to Avoid

  • Never delay culture collection before starting antibiotics—this compromises your ability to tailor therapy and contributes to resistance 1
  • Do not continue ineffective therapy indefinitely—if no improvement occurs after an appropriate antibiotic course, proceed to catheter removal or salvage procedures 1
  • Recognize that approximately 25% of Gram-positive organisms may be mupirocin-resistant with long-term prophylactic use 5

References

Guideline

Treatment of Exit Site Infections in CAPD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients.

Journal of the American Society of Nephrology : JASN, 1992

Research

Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2022

Research

Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.